ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
68,917.18
1.46%
S&P 500
5,304.72
0.70%
Dow Jones
39,069.59
0.01%
US Dollar vs Yen
156.9085
-0.04%
Brent Oil
81.92
0.75%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Karuna Therapeutics Inc (KRTX)

  7. Karuna Therapeutics Inc (KRTX) ニュース

KRTX

Karuna Therapeutics (KRTX)

Karuna Therapeutics Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:KRTX
日付受信時刻ニュースソース見出しコード企業名
2024/03/1206 : 10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRTXKaruna Therapeutics Inc
2024/03/0907 : 01Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:KRTXKaruna Therapeutics Inc
2024/03/0120 : 02Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:KRTXKaruna Therapeutics Inc
2024/03/0120 : 01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRTXKaruna Therapeutics Inc
2024/02/2220 : 39Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:KRTXKaruna Therapeutics Inc
2024/02/2220 : 32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRTXKaruna Therapeutics Inc
2024/02/2220 : 30Business WireKaruna Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides General Business UpdateNASDAQ:KRTXKaruna Therapeutics Inc
2024/02/1606 : 53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRTXKaruna Therapeutics Inc
2024/02/1606 : 50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRTXKaruna Therapeutics Inc
2024/02/1606 : 45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRTXKaruna Therapeutics Inc
2024/02/1606 : 42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRTXKaruna Therapeutics Inc
2024/02/1500 : 04Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:KRTXKaruna Therapeutics Inc
2024/02/1307 : 11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRTXKaruna Therapeutics Inc
2024/02/1307 : 09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRTXKaruna Therapeutics Inc
2024/02/0901 : 56Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:KRTXKaruna Therapeutics Inc
2024/02/0606 : 12Edgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger or acquisitionNASDAQ:KRTXKaruna Therapeutics Inc
2024/01/2220 : 05Edgar (US Regulatory)Form PREM14A - Preliminary proxy statements relating to merger or acquisitionNASDAQ:KRTXKaruna Therapeutics Inc
2024/01/1706 : 18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRTXKaruna Therapeutics Inc
2024/01/1006 : 34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRTXKaruna Therapeutics Inc
2024/01/0906 : 18Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:KRTXKaruna Therapeutics Inc
2024/01/0900 : 06PR Newswire (US)Kuehn Law Encourages KRTX, DSKE, RYZB, and GRCL Investors to Contact Law FirmNASDAQ:KRTXKaruna Therapeutics Inc
2023/12/3006 : 43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRTXKaruna Therapeutics Inc
2023/12/2307 : 20Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:KRTXKaruna Therapeutics Inc
2023/12/2307 : 20Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:KRTXKaruna Therapeutics Inc
2023/12/2307 : 07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRTXKaruna Therapeutics Inc
2023/12/2306 : 28Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:KRTXKaruna Therapeutics Inc
2023/12/2306 : 22Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:KRTXKaruna Therapeutics Inc
2023/12/2306 : 12Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:KRTXKaruna Therapeutics Inc
2023/12/2305 : 30PR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Karuna Therapeutics, Inc.NASDAQ:KRTXKaruna Therapeutics Inc
2023/12/2301 : 15Dow Jones NewsTrending: Bristol Myers to Buy Karuna Therapeutics for $14 BillionNASDAQ:KRTXKaruna Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:KRTX

最近閲覧した銘柄

LSE
13NC
Hsbc Bk. 27
COIN
TOADETH
LuckyToadv3
EU
J918S
J918S
BIT
UC7PUJ
Unicredit Bank
TSX
ZID
BMO MSCI India ESG Leade...
BOV
PCMR5L
Princomar Ind Pesca PNA
TSXV
CRB
Cariboo Rose Resources
ASX
LAT
Latin Gold
ASX
ORGKOP
POLO
DYPUSDT
DeFiYieldProtocol
BIT
UC5LUZ
Unicredit Bank
BIT
F14628
Vontobel Financial Produ...
TSX
ZCN
BMO S&P TSX Capped Compo...
NASDAQ
FTSV
Forty Seven
EU
H824T
H824T
BIT
UC4ST4
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有